Dr
Richard
Jenkins

Partner & Patent Attorney

York Office

Electronics

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 781 071 1455
Email. [email protected]

Experience

Richard has over 20 years experience in the patent profession, following his time at Oxford University during which he obtained his degree and doctorate in physics and worked as a post-doctoral research assistant in the field of superconductivity (studying both low and high temperature materials). His academic background includes final year modules in electronics and condensed matter physics, and years working as a demonstrator on the electronics practical course for physics undergraduates.

Richard leads a team providing European patent drafting and prosecution services to one of the world's largest mobile telecoms companies, obtaining granted patents at a rate of over two per day in this fast moving field.

Richard and his colleagues have pioneered the use of video conferencing for efficient, successful attendance at EPO Oral Proceedings before the examining division, typically attending around 100 OPs per year.

Richard also has extensive experience advising University and SME clients on IP strategy, and works closely with those clients, providing drafting and prosecution services in addition to support with invention harvesting, to build substantial, commercially-focused patent portfolios, for example in the field of printed and flexible electronics.

Qualifications

Patent Attorney

Chartered (UK)
European


BA

BA (Hons) Physics, Oxford University

PHD

D.Phil. Physics, Oxford University

Conferences: 2019

May 18th 2019

INTA 141st Annual Meeting 2019 - Boston

Attended

Event details

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.